A Retrospective Audit Of Biojet® Prostate Fusion Biopsies Amongst Patients Seen In A High-Volume Private Referral Centre In Cape Town Between January 2017 And April 2020

dc.contributor.advisorKaestner, Lisa-Ann
dc.contributor.authorPatel, Bhavinkumar
dc.date.accessioned2024-05-31T11:56:55Z
dc.date.available2024-05-31T11:56:55Z
dc.date.issued2023
dc.date.updated2024-05-31T11:23:20Z
dc.description.abstractIntroduction: The field of prostate cancer has seen a dramatic change in its approach to diagnosis, from the advent of PSA in the 1980s to the transrectal ultrasound guided 12 core biopsies with a false negative rate of approximately 30%. Recent advances in this field involve fusing MRI images with real-time ultrasound images to guide the surgeon. The aim of the study was to evaluate the performance of Biojet® prostate fusion biopsy system in a high-volume private referral centre. Methods: Retrospective observational audit of men who presented to a private urology practice in Cape Town for Biojet® prostate fusion biopsy based on clinical suspicion for prostate cancer. Data were collected as per the recommendations of the Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate group and anonymously entered onto a Redcap database. Results: The median age of the patient population was 64 (SD 9.124) years. The median PSA level was 6.5 ng/ml (IQR- 4.7). Most patients (78/135) had a clinical stage of T1c (57%). In the biopsy naïve group, a total of 103 PIRADS lesions were identified. Amongst the PIRADS 3 lesions 15/28 lesions (53%) had a positive cancer diagnosis. Of the PIRADS 4 lesions 37/60 lesions (62%) had a positive cancer diagnosis and in the PIRADS 5 group 13/15 lesions (87%) had a positive cancer diagnosis. 21 of the 42 men (50%) with a previous negative prostate biopsy had a positive cancer diagnosis using the Biojet® prostate fusion biopsy. Conclusion: In this study the Biojet® prostate fusion biopsy performed similar to other international studies however the pickup rate of cancer in those who had a previous negative biopsy was higher than those seen in the other global studies.
dc.identifier.apacitationPatel, B. (2023). <i>A Retrospective Audit Of Biojet® Prostate Fusion Biopsies Amongst Patients Seen In A High-Volume Private Referral Centre In Cape Town Between January 2017 And April 2020</i>. (). ,Faculty of Health Sciences ,Division of General Surgery. Retrieved from http://hdl.handle.net/11427/39803en_ZA
dc.identifier.chicagocitationPatel, Bhavinkumar. <i>"A Retrospective Audit Of Biojet® Prostate Fusion Biopsies Amongst Patients Seen In A High-Volume Private Referral Centre In Cape Town Between January 2017 And April 2020."</i> ., ,Faculty of Health Sciences ,Division of General Surgery, 2023. http://hdl.handle.net/11427/39803en_ZA
dc.identifier.citationPatel, B. 2023. A Retrospective Audit Of Biojet® Prostate Fusion Biopsies Amongst Patients Seen In A High-Volume Private Referral Centre In Cape Town Between January 2017 And April 2020. . ,Faculty of Health Sciences ,Division of General Surgery. http://hdl.handle.net/11427/39803en_ZA
dc.identifier.ris TY - Thesis / Dissertation AU - Patel, Bhavinkumar AB - Introduction: The field of prostate cancer has seen a dramatic change in its approach to diagnosis, from the advent of PSA in the 1980s to the transrectal ultrasound guided 12 core biopsies with a false negative rate of approximately 30%. Recent advances in this field involve fusing MRI images with real-time ultrasound images to guide the surgeon. The aim of the study was to evaluate the performance of Biojet® prostate fusion biopsy system in a high-volume private referral centre. Methods: Retrospective observational audit of men who presented to a private urology practice in Cape Town for Biojet® prostate fusion biopsy based on clinical suspicion for prostate cancer. Data were collected as per the recommendations of the Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate group and anonymously entered onto a Redcap database. Results: The median age of the patient population was 64 (SD 9.124) years. The median PSA level was 6.5 ng/ml (IQR- 4.7). Most patients (78/135) had a clinical stage of T1c (57%). In the biopsy naïve group, a total of 103 PIRADS lesions were identified. Amongst the PIRADS 3 lesions 15/28 lesions (53%) had a positive cancer diagnosis. Of the PIRADS 4 lesions 37/60 lesions (62%) had a positive cancer diagnosis and in the PIRADS 5 group 13/15 lesions (87%) had a positive cancer diagnosis. 21 of the 42 men (50%) with a previous negative prostate biopsy had a positive cancer diagnosis using the Biojet® prostate fusion biopsy. Conclusion: In this study the Biojet® prostate fusion biopsy performed similar to other international studies however the pickup rate of cancer in those who had a previous negative biopsy was higher than those seen in the other global studies. DA - 2023 DB - OpenUCT DP - University of Cape Town KW - General Surgery LK - https://open.uct.ac.za PY - 2023 T1 - A Retrospective Audit Of Biojet® Prostate Fusion Biopsies Amongst Patients Seen In A High-Volume Private Referral Centre In Cape Town Between January 2017 And April 2020 TI - A Retrospective Audit Of Biojet® Prostate Fusion Biopsies Amongst Patients Seen In A High-Volume Private Referral Centre In Cape Town Between January 2017 And April 2020 UR - http://hdl.handle.net/11427/39803 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/39803
dc.identifier.vancouvercitationPatel B. A Retrospective Audit Of Biojet® Prostate Fusion Biopsies Amongst Patients Seen In A High-Volume Private Referral Centre In Cape Town Between January 2017 And April 2020. []. ,Faculty of Health Sciences ,Division of General Surgery, 2023 [cited yyyy month dd]. Available from: http://hdl.handle.net/11427/39803en_ZA
dc.language.rfc3066eng
dc.publisher.departmentDivision of General Surgery
dc.publisher.facultyFaculty of Health Sciences
dc.subjectGeneral Surgery
dc.titleA Retrospective Audit Of Biojet® Prostate Fusion Biopsies Amongst Patients Seen In A High-Volume Private Referral Centre In Cape Town Between January 2017 And April 2020
dc.typeThesis / Dissertation
dc.type.qualificationlevelMasters
dc.type.qualificationlevelMMed
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
thesis_hsf_2023_patel bhavinkumar.pdf
Size:
845.79 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.72 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections